These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4792502)

  • 1. Serum CEA in normal individuals and in clinical disorders.
    Booth SN; King J; Leonard J; Dykes PW
    Ann Immunol (Paris); 1973 Nov; 124(4):631-2. PubMed ID: 4792502
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological diagnosis and prognosis of digestive tract cancer: some clinical considerations.
    Zamcheck N
    Ann Immunol (Paris); 1973 Nov; 124(4):635-40. PubMed ID: 4792503
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
    McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
    Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the carcinoembryonic antigen in clinical medicine].
    Piantino P; Gaia E; Garrone C; Bonardi O; Pecchio F
    Minerva Dietol Gastroenterol; 1980; 26(1):35-45. PubMed ID: 6990297
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of the determination of carcinoembryonic antigen (CEA) in benign and tumoral digestive pathology, chronic hepathopathies and hepatomas: study of 190 cases].
    Escudero Navarro JM; Rodrigo Saez L; Morcillo Herrera L; Faedo Presa I; Cornago Sánchez A; Pérez Alvarez R; García Saavedra L
    Rev Esp Enferm Apar Dig; 1980 Sep; 58(3):267-74. PubMed ID: 6256829
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of carcinoembryonic antigen in clinical medicine.
    Beatty JD; Terz JJ
    Prog Clin Cancer; 1982; 8():9-29. PubMed ID: 6760251
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoembryonic antigen in benign and malignant diseases of the digestive tract.
    Zamcheck N; Moore TL; Dhar P; Kupchik HZ; Sorokin JJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():433-9. PubMed ID: 4659055
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ganglioside and carcinoembryonic antigens in the diagnosis of malignant tumors of the gastrointestinal tract].
    Ivanov PK; Samoĭlenko VM
    Vopr Onkol; 1984; 30(9):55-9. PubMed ID: 6495695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tissue polypeptide antigen (TPA) as a tumor marker in disorders of the digestive tract: comparison with CEA].
    Piantino P; Tappero G; Cerchier A; Pecchio F; Tridico F; Cattaneo U
    Minerva Med; 1986 Apr; 77(16):617-20. PubMed ID: 3703360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen (CEA): a comparison of the Farr and Z-gel methods for CEA detection in benign and malignant diseases.
    Band P; Hyde H; Feldstein M; McPherson I; Patwardhan V
    Eur J Cancer (1965); 1973 Aug; 9(8):597-602. PubMed ID: 4788847
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
    Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
    Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
    Staab HJ
    Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
    [No Abstract]   [Full Text] [Related]  

  • 13. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases.
    Zamcheck N
    Adv Intern Med; 1974; 19():413-33. PubMed ID: 4592719
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical usefulness of CEA assay.
    Luporini G; Mangiarotti F; Fraschini P; Labianca R; Tassi GC; De Barbieri A
    Boll Ist Sieroter Milan; 1976; 55(2):151-63. PubMed ID: 1023883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous measurements of tumour-associated antigens in gastrointestinal cancer.
    Go VL
    Clin Gastroenterol; 1976 Sep; 5(3):645-51. PubMed ID: 66112
    [No Abstract]   [Full Text] [Related]  

  • 16. CEA MARIA serum levels in gastrointestinal pathologies.
    Ruibal A; Pombo L; Soriano A; Genollá J; Duque JJ; Fombellida JC
    Bull Cancer; 1988; 75(2):225-7. PubMed ID: 3359066
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective evaluation of the diagnostic efficacy of CA 19-9 assay as a marker for gastrointestinal cancers.
    Andriulli A; Gindro T; Piantino P; Farini R; Cavallini G; Piazzi L; Naccarato R; Dobrilla G; Verme G; Scuro LA
    Digestion; 1986; 33(1):26-33. PubMed ID: 3940235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress in tumor markers of the digestive system].
    Mori T
    Gan No Rinsho; 1983 May; 29(6):663-71. PubMed ID: 6876437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies].
    Dienst C; Clodius T; Oldörp T; Uhlenbruck G; Diehl V
    Med Klin (Munich); 1987 Jan; 82(2):45-50. PubMed ID: 3470595
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of tumor markers in the diagnosis and management of gastrointestinal cancer.
    Heptner G; Domschke S; Domschke W
    Hepatogastroenterology; 1986 Aug; 33(4):140-4. PubMed ID: 2428718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.